Literature DB >> 6802200

Cutaneous manifestation of neurofibromatosis: cellular interaction, pigmentation, and mast cells.

V M Riccardi.   

Abstract

The patchy, mosaic nature of the hyperpigmentation defect in neurofibromatosis (NF) is shown to be compatible with a cell-cell interaction model involving at least 2, and perhaps 3 cell types. Two approaches to analysis of the cellular interaction model are outlined in detail: 1) Demonstration of the more or less random number, size, and distribution of café-au-lait spots (CLS); 2) Documentation of topographic features of hyperpigmentation and neurofibroma skin lesions with special significance, including: a) Localized, intense pruritus coincident with developing or numerous neurofibromas, responding to treatment with antihistamines or oral disodium cromoglycate (the mast cell is suggested as a mediator of the pruritus and perhaps of neurofibroma development); b) The high frequency of areolar neurofibromas in postpubertal NF females, suggesting a localized estrogenic effect on neurofibroma development; c) The recognition that the usual NF freckling (eg axillary) is essentially restricted to intertriginous zones and that they therefore probably have a different mechanism of origin than do CLS.

Entities:  

Mesh:

Year:  1981        PMID: 6802200

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  17 in total

Review 1.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

2.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Authors:  Lu Q Le; Tracey Shipman; Dennis K Burns; Luis F Parada
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

3.  The plexiform neurofibroma microenvironment.

Authors:  Feng-Chun Yang; Karl Staser; D Wade Clapp
Journal:  Cancer Microenviron       Date:  2012-07-24

Review 4.  Mast cells and the neurofibroma microenvironment.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

Review 5.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

6.  Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.

Authors:  Andrew S McDaniel; Jayme D Allen; Su-Jung Park; Zahara M Jaffer; Elizabeth G Michels; Sarah J Burgin; Shi Chen; Waylan K Bessler; Clemens Hofmann; David A Ingram; Jonathan Chernoff; D Wade Clapp
Journal:  Blood       Date:  2008-09-02       Impact factor: 22.113

7.  Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.

Authors:  Feng-Chun Yang; David A Ingram; Shi Chen; Cynthia M Hingtgen; Nancy Ratner; Kelly R Monk; Travis Clegg; Hilary White; Laura Mead; Mary Jo Wenning; David A Williams; Reuben Kapur; Simon J Atkinson; D Wade Clapp
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

Review 8.  It takes two to tango: mast cell and Schwann cell interactions in neurofibromas.

Authors:  David H Viskochil
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions.

Authors:  C N Metz; P Thomas; M A Davitz
Journal:  Am J Pathol       Date:  1992-06       Impact factor: 4.307

Review 10.  Advances in the treatment of neurofibromatosis-associated tumours.

Authors:  Andrew L Lin; David H Gutmann
Journal:  Nat Rev Clin Oncol       Date:  2013-08-13       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.